NCT06452719

Phase 2Interventional

Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.

View on ClinicalTrials.gov ↗

Timeline

Start date: Aug 22, 2024
Primary completion: Jul 15, 2025
Completion date: Jul 15, 2025
First posted: Jun 11, 2024
Last posted: Aug 29, 2024
Enrollment: 30
Arms / groups: 1 / —
Source: AACT · ctgov ingestion

Drugs studied

misoprostol
letrozole

Indications studied

Abortion, Spontaneous
Dermatology

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.

NCT06452719

Timeline

Sponsors

Drugs studied

Indications studied